{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T11:46:43Z","timestamp":1697197603672},"reference-count":29,"publisher":"Tohoku University Medical Press","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2020]]},"DOI":"10.1620\/tjem.252.287","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T22:07:53Z","timestamp":1605737273000},"page":"287-296","source":"Crossref","is-referenced-by-count":0,"title":["Daily Monitoring of Serum &lt;i&gt;Wisteria floribunda&lt;\/i&gt; Agglutinin-Positive Mac-2 Binding Protein Is Useful for Predicting Therapeutic Effect of Tolvaptan in Cirrhotic Ascites"],"prefix":"10.1620","volume":"252","author":[{"given":"Masaaki","family":"Takamura","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Sakamaki","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Arao","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Setsu","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroteru","family":"Kamimura","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yokoo","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenya","family":"Kamimura","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsunori","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Terai","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Abe, M., Miyake, T., Kuno, A., Imai, Y., Sawai, Y., Hino, K., Hara, Y., Hige, S., Sakamoto, M., Yamada, G., Kage, M., Korenaga, M., Hiasa, Y., Mizokami, M. &amp; Narimatsu, H. (2015) Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease. <i>J. Gastroenterol.<\/i>, 50, 776-784.","DOI":"10.1007\/s00535-014-1007-2"},{"key":"2","unstructured":"Atsukawa, M., Tsubota, A., Kato, K., Abe, H., Shimada, N., Asano, T., Ikegami, T., Koeda, M., Okubo, T., Arai, T., Nakagawa-Iwashita, A., Yoshida, Y., Hayama, K., Itokawa, N., Kondo, C., et al. (2018) Analysis of factors predicting the response to tolvaptan in patients with liver cirrhosis and hepatic edema. <i>J. Gastroenterol. Hepatol.<\/i>, 33, 1256-1263."},{"key":"3","unstructured":"Atsukawa, M., Tsubota, A., Takaguchi, K., Toyoda, H., Iwasa, M., Ikegami, T., Chuma, M., Nozaki, A., Uojima, H., Hiraoka, A., Fukunishi, S., Yokohama, K., Tada, T., Kato, K., Abe, H., et al. (2020) Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema. <i>J. Gastroenterol. Hepatol.<\/i>, 35, 1229-1237."},{"key":"4","unstructured":"Bekki, Y., Yoshizumi, T., Shimoda, S., Itoh, S., Harimoto, N., Ikegami, T., Kuno, A., Narimatsu, H., Shirabe, K. &amp; Maehara, Y. (2017) Hepatic stellate cells secreting WFA<sup>+<\/sup>-M2BP: its role in biological interactions with Kupffer cells. <i>J. Gastroenterol. Hepatol.<\/i>, 32, 1387-1393."},{"key":"5","unstructured":"Bernardi, M., De Palma, R., Trevisani, F., Santini, C., Servadei, D. &amp; Gasbarrini, G. (1985) Comparative pharmacodynamics of furosemide and muzolimine in cirrhosis. Study on renal sodium and potassium handling and renin-aldosterone axis. <i>Z. Kardiol.<\/i>, 74 Suppl 2, 129-134."},{"key":"6","doi-asserted-by":"crossref","unstructured":"Costello-Boerrigter, L.C., Smith, W.B., Boerrigter, G., Ouyang, J., Zimmer, C.A., Orlandi, C. &amp; Burnett, J.C. Jr. (2006) Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure. <i>Am. J. Physiol. Renal Physiol.<\/i>, 290, F273-278.","DOI":"10.1152\/ajprenal.00195.2005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Gin\u00e9s, P., Quintero, E., Arroyo, V., Ter\u00e9s, J., Bruguera, M., Rimola, A., Caballer\u00eda, J., Rod\u00e9s, J. &amp; Rozman, C. (1987) Compensated cirrhosis: natural history and prognostic factors. <i>Hepatology<\/i>, 7, 122-128.","DOI":"10.1002\/hep.1840070124"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Haga, Y., Kanda, T., Sasaki, R., Nakamura, M., Takahashi, K., Wu, S., Yasui, S., Arai, M., Nakamoto, S. &amp; Yokosuka, O. (2016) Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein could not always predict early cirrhosis in non-viral liver diseases. <i>Diseases<\/i>, 4, 38.","DOI":"10.3390\/diseases4040038"},{"key":"9","unstructured":"Hiramine, Y., Uto, H., Imamura, Y., Hiwaki, T., Kure, T., Ijuin, S., Oda, K., Mawatari, S., Kumagai, K., Tokunaga, K., Higashi, H., Kanetsuki, I., Kubozono, O., Maenohara, S. &amp; Ido, A. (2017) Efficacy of vasopressin V2 receptor antagonist tolvaptan in treatment of hepatic edema. <i>Hepatol. Res.<\/i>, 47, 542-557."},{"key":"10","unstructured":"Hiramine, Y., Uojima, H., Nakanishi, H., Hiramatsu, A., Iwamoto, T., Kimura, M., Kawaratani, H., Terai, S., Yoshiji, H., Uto, H., Sakaida, I., Izumi, N., Okita, K. &amp; Koike, K. (2018) Response criteria of tolvaptan for the treatment of hepatic edema. <i>J. Gastroenterol.<\/i>, 53, 258-268."},{"key":"11","unstructured":"Inohara, H., Akahani, S., Koths, K. &amp; Raz, A. (1996) Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion. <i>Cancer Res.<\/i>, 56, 4530-4534."},{"key":"12","unstructured":"Ishii, A., Nishikawa, H., Enomoto, H., Iwata, Y., Kishino, K., Shimono, Y., Hasegawa, K., Nakano, C., Takata, R., Nishimura, T., Yoh, K., Aizawa, N., Sakai, Y., Ikeda, N., Takashima, T., et al. (2017) Clinical implications of serum Wisteria floribunda agglutinin-positive Mac-2-binding protein in treatment-naive chronic hepatitis B. <i>Hepatol. Res.<\/i>, 47, 204-215."},{"key":"13","doi-asserted-by":"crossref","unstructured":"Kuno, A., Ikehara, Y., Tanaka, Y., Ito, K., Matsuda, A., Sekiya, S., Hige, S., Sakamoto, M., Kage, M., Mizokami, M. &amp; Narimatsu, H. (2013a) A serum \u201csweet-doughnut\u201d protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. <i>Sci. Rep.<\/i>, 3, 1065.","DOI":"10.1038\/srep01065"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Kuno, A., Sato, T., Shimazaki, H., Unno, S., Saitou, K., Kiyohara, K., Sogabe, M., Tsuruno, C., Takahama, Y., Ikehara, Y. &amp; Narimatsu, H. (2013b) Reconstruction of a robust glycodiagnostic agent supported by multiple lectin-assisted glycan profiling. <i>Proteomics Clin. Appl.<\/i>, 7, 642-647.","DOI":"10.1002\/prca.201300010"},{"key":"15","unstructured":"Kurokawa, T., Tsuda, M. &amp; Sugino, Y. (1976) Purification and characterization of a lectin from Wistaria floribunda seeds. <i>J. Biol. Chem.<\/i>, 251, 5686-5693."},{"key":"16","unstructured":"McConnell, M. &amp; Iwakiri, Y. (2018) Biology of portal hypertension. <i>Hepatol. Int.<\/i>, 12, 11-23."},{"key":"17","doi-asserted-by":"crossref","unstructured":"Nagata, H., Nakagawa, M., Nishimura-Sakurai, Y., Asano, Y., Tsunoda, T., Miyoshi, M., Kaneko, S., Goto, F., Otani, S., Kawai-Kitahata, F., Murakawa, M., Nitta, S., Itsui, Y., Azuma, S., Kakinuma, S., et al. (2016) Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy. <i>Hepatol. Int.<\/i>, 10, 956-964.","DOI":"10.1007\/s12072-016-9754-1"},{"key":"18","unstructured":"Nakagawa, A., Atsukawa, M., Tsubota, A., Kondo, C., Okubo, T., Arai, T., Itokawa, N., Narahara, Y. &amp; Iwakiri, K. (2016) Usefulness of portal vein pressure for predicting the effects of tolvaptan in cirrhotic patients. <i>World J. Gastroenterol.<\/i>, 22, 5104-5113."},{"key":"19","doi-asserted-by":"crossref","unstructured":"Nishikawa, H., Enomoto, H., Iwata, Y., Hasegawa, K., Nakano, C., Takata, R., Nishimura, T., Yoh, K., Aizawa, N., Sakai, Y., Ikeda, N., Takashima, T., Iijima, H. &amp; Nishiguchi, S. (2016) Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level and high-sensitivity C-reactive protein concentration in autoimmune hepatitis. <i>Hepatol. Res.<\/i>, 46, 613-621.","DOI":"10.1111\/hepr.12596"},{"key":"20","unstructured":"Piller, V., Piller, F. &amp; Cartron, J.P. (1990) Comparison of the carbohydrate-binding specificities of seven N-acetyl-D-galactosamine-recognizing lectins. <i>Eur. J. Biochem.<\/i>, 191, 461-466."},{"key":"21","unstructured":"Planas, R., Montoliu, S., Balleste, B., Rivera, M., Miquel, M., Masnou, H., Galeras, J.A., Gimenez, M.D., Santos, J., Cirera, I., Morillas, R.M., Coll, S. &amp; Sola, R. (2006) Natural history of patients hospitalized for management of cirrhotic ascites. <i>Clin. Gastroenterol. Hepatol.<\/i>, 4, 1385-1394."},{"key":"22","unstructured":"Pugh, R.N., Murray-Lyon, I.M., Dawson, J.L., Pietroni, M.C. &amp; Williams, R. (1973) Transection of the oesophagus for bleeding oesophageal varices. <i>Br. J. Surg.<\/i>, 60, 646-649."},{"key":"23","doi-asserted-by":"crossref","unstructured":"Sakaida, I., Kawazoe, S., Kajimura, K., Saito, T., Okuse, C., Takaguchi, K., Okada, M. &amp; Okita, K.; ASCITES-DOUBLEBLIND Study Group (2014) Tolvaptan for improvement of hepatic edema: a phase 3, multicenter, randomized, double-blind, placebo-controlled trial. <i>Hepatol. Res.<\/i>, 44, 73-82.","DOI":"10.1111\/hepr.12098"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Sakaida, I., Terai, S., Kurosaki, M., Yasuda, M., Okada, M., Bando, K. &amp; Fukuta, Y. (2017) Effectiveness and safety of tolvaptan in liver cirrhosis patients with edema: interim results of post-marketing surveillance of tolvaptan in liver cirrhosis (START study). <i>Hepatol. Res.<\/i>, 47, 1137-1146.","DOI":"10.1111\/hepr.12852"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Sakaida, I., Terai, S., Kurosaki, M., Okada, M., Hirano, T. &amp; Fukuta, Y. (2020) Real-world effectiveness and safety of tolvaptan in liver cirrhosis patients with hepatic edema: results from a post-marketing surveillance study (START study). <i>J. Gastroenterol.<\/i>, 55, 800-810.","DOI":"10.1007\/s00535-020-01691-x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Shirabe, K., Bekki, Y., Gantumur, D., Araki, K., Ishii, N., Kuno, A., Narimatsu, H. &amp; Mizokami, M. (2018) Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis. <i>J. Gastroenterol.<\/i>, 53, 819-826.","DOI":"10.1007\/s00535-017-1425-z"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Tsien, C. &amp; Wong, F. (2013) The impact of acute kidney injury in cirrhosis: does definition matter? <i>Gut<\/i>, 62, 1091-1092.","DOI":"10.1136\/gutjnl-2013-304576"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Uojima, H., Kinbara, T., Hidaka, H., Sung, J.H., Ichida, M., Tokoro, S., Masuda, S., Takizawa, S., Sasaki, A., Koizumi, K., Egashira, H. &amp; Kako, M. (2017) Close correlation between urinary sodium excretion and response to tolvaptan in liver cirrhosis patients with ascites. <i>Hepatol. Res.<\/i>, 47, E14-E21.","DOI":"10.1111\/hepr.12716"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Yamasaki, K., Tateyama, M., Abiru, S., Komori, A., Nagaoka, S., Saeki, A., Hashimoto, S., Sasaki, R., Bekki, S., Kugiyama, Y., Miyazoe, Y., Kuno, A., Korenaga, M., Togayachi, A., Ocho, M., et al. (2014) Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients. <i>Hepatology<\/i>, 60, 1563-1570.","DOI":"10.1002\/hep.27305"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/252\/4\/252_287\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T17:16:09Z","timestamp":1697130969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/252\/4\/252_287\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.252.287","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}